71% Use Synthetic Cannabinoids To Avoid A Positive Drug Test

Synthetic Cannabinoid Use

More than one-third (38%) of adult patients in a Midwestern substance use disorder residential treatment program reported ever using synthetic cannabinoids.

Nearly all of these patients reported multiple reasons for use, with the most common being “curiosity” (91%) and “to feel good or get high” (89%).

A substantial number also reported that they used synthetic cannabinoids “to relax or relieve tension” (71%) or “to get high without having a positive drug test” (71%; see figure below). Prior studies have also found that synthetic cannabinoids are used to avoid positive drug tests (see CESAR FAX, Volume 22, Issue 27).

According to the authors, “consuming synthetic cannabinoids can complicate the treatment process, especially when urine tests do not identify all synthetic cannabinoids” (p. 2). The authors note that a limitation of their study is that it “lacked toxicology screening to verify recent substance uses or whether the substances patients reported were synthetic cannabinoids were actually synthetic cannabinoids and not another substance” (p. 3).

 

Synthetic Cannabinoid Use

NOTE: Reasons were assessed with a checklist of 13 items developed by combining motives from Monitoring the Future’s marijuana motives questions and prior research on synthetic cannabinoid use.

SOURCE: Adapted by CESAR from Bonar, E.E., Ashrafioun, L., and Ilgen, M.A, “Synthetic Cannabinoid Use Among Patients in Residential Substance Use Disorder Treatment: Prevalence, Motives, and Correlates,” Drug and Alcohol Dependence, In Press, 2014. For more information, contact Erin Bonar at [email protected]


Share Your Story With Us

If you have firsthand experience with synthetic marijuana and are willing to share your story, you can help other people to gain new insights into their own struggle with this awful drug.

Name You Want To Be Used (Required)

Your Email (Required)

Your Story

Can We Anonymously Post Your Story To Help Others?
(Required)
YesNo

Type The Letters In The Box

captcha

   

Let's Stay In Touch!

Subscribe to get the latest submitted stories delivered to your inbox. Join Our Mailing List